OBJECTIVE: To investigate whether the presence of decay-accelerating factor (or CD55), an intrinsic complement regulator, protects against the development of vascular disease, given that complement activation can affect leukocytes and platelets. METHODS AND RESULTS: Leukocyte-platelet complexes are critical for the initiation and progression of atherosclerosis and restenosis; however, the mechanism by which these processes promote vascular injury is incompletely defined. We performed femoral artery wire injury in Daf1(-/-) mice and their wild-type controls. Leukocyte accumulation, cellular proliferation, and neointimal thickening were enhanced in Daf1(-/-) mice versus wild-type mice. Deficiency of either the C3a or the C5a receptor, respectively, reversed the increased vascular inflammation, cellular proliferation, and neointimal formation in Daf1(-/-) mice. CONCLUSIONS: Decay-accelerating factor control of C3a and C5a generation and prevention of the binding of these activation fragments to the C3a and C5a receptors are critical for the biological response to vascular injury. Targeting the C3a and C5a receptors may be useful for the prevention of neointimal hyperplasia.
OBJECTIVE: To investigate whether the presence of decay-accelerating factor (or CD55), an intrinsic complement regulator, protects against the development of vascular disease, given that complement activation can affect leukocytes and platelets. METHODS AND RESULTS: Leukocyte-platelet complexes are critical for the initiation and progression of atherosclerosis and restenosis; however, the mechanism by which these processes promote vascular injury is incompletely defined. We performed femoral artery wire injury in Daf1(-/-) mice and their wild-type controls. Leukocyte accumulation, cellular proliferation, and neointimal thickening were enhanced in Daf1(-/-) mice versus wild-type mice. Deficiency of either the C3a or the C5a receptor, respectively, reversed the increased vascular inflammation, cellular proliferation, and neointimal formation in Daf1(-/-) mice. CONCLUSIONS:Decay-accelerating factor control of C3a and C5a generation and prevention of the binding of these activation fragments to the C3a and C5a receptors are critical for the biological response to vascular injury. Targeting the C3a and C5a receptors may be useful for the prevention of neointimal hyperplasia.
Authors: Dmitri V Gnatenko; John J Dunn; Sean R McCorkle; David Weissmann; Peter L Perrotta; Wadie F Bahou Journal: Blood Date: 2002-11-14 Impact factor: 22.113
Authors: Ines J Laudes; Jeffrey C Chu; Markus Huber-Lang; Ren-Feng Guo; Niels C Riedemann; J Vidya Sarma; Fakhri Mahdi; Hedwig S Murphy; Cecilia Speyer; Kristina T Lu; John D Lambris; Firas S Zetoune; Peter A Ward Journal: J Immunol Date: 2002-11-15 Impact factor: 5.422
Authors: Merce Roque; William J H Kim; Michaela Gazdoin; Alia Malik; Ernane D Reis; John T Fallon; Juan J Badimon; Israel F Charo; Mark B Taubman Journal: Arterioscler Thromb Vasc Biol Date: 2002-04-01 Impact factor: 8.311
Authors: Viola W Y Leung; Sheng Yun; Marina Botto; Justin C Mason; Talat H Malik; Wenchao Song; Danielle Paixao-Cavalcante; Matthew C Pickering; Joseph J Boyle; Dorian O Haskard Journal: Am J Pathol Date: 2009-09-03 Impact factor: 4.307
Authors: Ming-Shih Hwang; Michael G Strainic; Elliot Pohlmann; Haesuk Kim; Elzbieta Pluskota; Diana L Ramirez-Bergeron; Edward F Plow; M Edward Medof Journal: J Cell Sci Date: 2019-03-28 Impact factor: 5.285
Authors: Sonia I Vlaicu; Alexandru Tatomir; Violeta Rus; Armugam P Mekala; Petru A Mircea; Florin Niculescu; Horea Rus Journal: Immunol Res Date: 2016-02 Impact factor: 2.829
Authors: Devin Cao; Michael G Strainic; Daniel Counihan; Shiva Sridar; Fengqi An; Wasim Hussain; Alvin H Schmaier; Marvin Nieman; M Edward Medof Journal: Am J Pathol Date: 2022-02 Impact factor: 4.307
Authors: Eileen M Bauer; Han Zheng; Suzy Comhair; Serpil Erzurum; Timothy R Billiar; Philip M Bauer Journal: PLoS One Date: 2011-12-14 Impact factor: 3.240